Interferon-γ-inducible protein-10 (IP-10 or CXCL10), which has been shown to play a role in inflammatory cell migration to the gut in ulcerative colitis (UC) (43–45), was significantly increased in the PALA-treated group (Figure 4B). The gene discussed is CXCL10; the disease is ulcerative colitis.